• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全长新德里金属β-内酰胺酶-1(NDM-1)抑制剂的发现。

Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).

机构信息

State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences, Nanjing, Jiangsu, China.

出版信息

PLoS One. 2013 May 13;8(5):e62955. doi: 10.1371/journal.pone.0062955. Print 2013.

DOI:10.1371/journal.pone.0062955
PMID:23675445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3652859/
Abstract

New Delhi metallo-β-lactmase-1 (NDM-1) has recently attracted extensive attention for its biological activities to catalyze the hydrolysis of almost all of β-lactam antibiotics. To study the catalytic property of NDM-1, the steady-kinetic parameters of NDM-1 toward several kinds of β-lactam antibiotics have been detected. It could effectively hydrolyze most β-lactams (k cat/K m ratios between 0.03 to 1.28 µmol⁻¹.s⁻¹), except aztreonam. We also found that thiophene-carboxylic acid derivatives could inhibit NDM-1 and have shown synergistic antibacterial activity in combination with meropenem. Flexible docking and quantum mechanics (QM) study revealed electrostatic interactions between the sulfur atom of thiophene-carboxylic acid derivatives and the zinc ion of NDM-1, along with hydrogen bond between inhibitor and His189 of NDM-1. The interaction models proposed here can be used in rational design of NDM-1 inhibitors.

摘要

新德里金属β-内酰胺酶-1(NDM-1)因其能够催化水解几乎所有β-内酰胺抗生素的生物学活性而受到广泛关注。为了研究 NDM-1 的催化特性,检测了 NDM-1 对几种β-内酰胺抗生素的稳态动力学参数。它可以有效水解大多数β-内酰胺类抗生素(k cat/K m 比值在 0.03 到 1.28 µmol⁻¹.s⁻¹ 之间),但不能水解氨曲南。我们还发现噻吩羧酸衍生物可以抑制 NDM-1,并与美罗培南联合显示出协同抗菌活性。柔性对接和量子力学(QM)研究揭示了噻吩羧酸衍生物的硫原子与 NDM-1 的锌离子之间的静电相互作用,以及抑制剂与 NDM-1 的 His189 之间的氢键。这里提出的相互作用模型可用于合理设计 NDM-1 抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/c277989ad2b0/pone.0062955.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/d60874656633/pone.0062955.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/09f363871ed3/pone.0062955.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/77953b5ebeec/pone.0062955.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/9b49c925a43f/pone.0062955.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/c277989ad2b0/pone.0062955.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/d60874656633/pone.0062955.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/09f363871ed3/pone.0062955.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/77953b5ebeec/pone.0062955.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/9b49c925a43f/pone.0062955.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/3652859/c277989ad2b0/pone.0062955.g005.jpg

相似文献

1
Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).全长新德里金属β-内酰胺酶-1(NDM-1)抑制剂的发现。
PLoS One. 2013 May 13;8(5):e62955. doi: 10.1371/journal.pone.0062955. Print 2013.
2
Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors.寡肽作为全长新德里金属β-内酰胺酶-1(NDM-1)抑制剂。
PLoS One. 2017 May 23;12(5):e0177293. doi: 10.1371/journal.pone.0177293. eCollection 2017.
3
New Delhi metallo-β-lactamase (NDM-1): an update.新德里金属β-内酰胺酶(NDM-1):最新进展
J Chemother. 2011 Oct;23(5):263-5. doi: 10.1179/joc.2011.23.5.263.
4
Phenotypic and studies for a series of synthetic thiosemicarbazones as New Delhi metallo-beta-lactamase carbapenemase inhibitors.一系列合成缩硫酮作为新德里金属β-内酰胺酶碳青霉烯酶抑制剂的表型和研究。
J Biomol Struct Dyn. 2022;40(24):14223-14235. doi: 10.1080/07391102.2021.2001379. Epub 2021 Nov 12.
5
The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.作为一种针对产 NDM-1 阳性大肠埃希菌的强效酶抑制剂,维地福卢米的活性和作用机制。
Eur J Med Chem. 2023 Mar 15;250:115225. doi: 10.1016/j.ejmech.2023.115225. Epub 2023 Feb 28.
6
A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1.一种关于新德里金属β-内酰胺酶-1水解机制的量子力学/分子力学研究。
J Comput Aided Mol Des. 2013 Mar;27(3):247-56. doi: 10.1007/s10822-012-9630-6. Epub 2013 Mar 2.
7
High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.高通量虚拟筛选、分子动力学模拟和酶动力学鉴定 ZINC84525623 为 NDM-1 的潜在抑制剂。
Int J Mol Sci. 2019 Feb 14;20(4):819. doi: 10.3390/ijms20040819.
8
Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.紫檀芪通过抑制新德里金属β-内酰胺酶的活性恢复新德里产金属β-内酰胺酶分离株对碳青霉烯类药物的敏感性。
Br J Pharmacol. 2019 Dec;176(23):4548-4557. doi: 10.1111/bph.14818. Epub 2019 Dec 9.
9
Inhibitor and substrate binding by New Delhi metallo-beta-lactamase-1: a molecular dynamics studies.新德里金属β-内酰胺酶-1与抑制剂和底物的结合:分子动力学研究
Curr Comput Aided Drug Des. 2014;10(3):197-204. doi: 10.2174/1574886309666141126145225.
10
Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.利塞膦酸盐和甲氨蝶呤是新德里金属β-内酰胺酶-1(NDM-1)的高亲和力抑制剂:药物再利用方法。
Molecules. 2022 Feb 14;27(4):1283. doi: 10.3390/molecules27041283.

引用本文的文献

1
Computational Analysis of Novel NDM‑1 Inhibitors: Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation, Molecular Docking, and Molecular Dynamics of Cyclic Borate Derivatives and Chromones.新型NDM-1抑制剂的计算分析:环状硼酸酯衍生物和色酮的吸收、分布、代谢、排泄及毒性评估、分子对接和分子动力学
ACS Omega. 2025 Jul 31;10(31):34212-34226. doi: 10.1021/acsomega.5c00407. eCollection 2025 Aug 12.
2
Pharmacophore-Based Study: An In Silico Perspective for the Identification of Potential New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors.基于药效团的研究:用于鉴定潜在新型德里金属β-内酰胺酶-1(NDM-1)抑制剂的计算机模拟视角
Pharmaceuticals (Basel). 2024 Sep 9;17(9):1183. doi: 10.3390/ph17091183.
3

本文引用的文献

1
Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.Cbf-K16 和 Cbf-A7 A13 通过穿透细胞质膜后与 DNA 结合,对携带 NDM-1 的大肠杆菌具有有效的抗菌活性。
J Pept Sci. 2013 Mar;19(3):173-80. doi: 10.1002/psc.2488. Epub 2013 Feb 7.
2
Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.从新西兰医院的肠杆菌科中鉴定和分子特征化产生新德里金属β-内酰胺酶-1(NDM-1)和 NDM-6 的细菌。
Int J Antimicrob Agents. 2012 Jun;39(6):529-33. doi: 10.1016/j.ijantimicag.2012.02.017. Epub 2012 Apr 21.
3
New Delhi Metallo-Beta-Lactamase Inhibitors: A Systematic Scoping Review.
新德里金属β-内酰胺酶抑制剂:一项系统的范围综述。
J Clin Med. 2024 Jul 18;13(14):4199. doi: 10.3390/jcm13144199.
4
Towards combating antibiotic resistance by exploring the quantitative structure-activity relationship of NDM-1 inhibitors.通过探索NDM-1抑制剂的定量构效关系来对抗抗生素耐药性。
EXCLI J. 2022 Nov 16;21:1331-1351. doi: 10.17179/excli2022-5380. eCollection 2022.
5
Molecular docking studies, in-silico ADMET predictions and synthesis of novel PEGA-nucleosides as antimicrobial agents targeting class B1 metallo-β-lactamases.分子对接研究、计算机辅助ADMET预测以及新型PEGA-核苷作为靶向B1类金属β-内酰胺酶的抗菌剂的合成。
In Silico Pharmacol. 2021 Apr 16;9(1):33. doi: 10.1007/s40203-021-00092-z. eCollection 2021.
6
Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.金属β-内酰胺酶:结构、功能、流行病学、治疗选择和研发管线。
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00397-20.
7
A mechanistic approach to prove the efficacy of combination therapy against New Delhi metallo-β-lactamases producing bacterial strain: a molecular and biochemical approach.采用一种机制方法来证明联合治疗对产生新德里金属β-内酰胺酶的细菌菌株的疗效:一种分子和生化方法。
Eur J Med Res. 2020 Jun 3;25(1):19. doi: 10.1186/s40001-020-00418-1.
8
High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.高通量虚拟筛选、分子动力学模拟和酶动力学鉴定 ZINC84525623 为 NDM-1 的潜在抑制剂。
Int J Mol Sci. 2019 Feb 14;20(4):819. doi: 10.3390/ijms20040819.
9
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.在医疗环境中 NDM 型金属β-内酰胺酶及其细菌生产者
Clin Microbiol Rev. 2019 Jan 30;32(2). doi: 10.1128/CMR.00115-18. Print 2019 Mar 20.
10
Targeting Metalloenzymes for Therapeutic Intervention.靶向金属酶治疗干预。
Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7.
Mechanistic and spectroscopic studies of metallo-β-lactamase NDM-1.
金属β-内酰胺酶 NDM-1 的机制和光谱研究。
Biochemistry. 2012 May 8;51(18):3839-47. doi: 10.1021/bi300056y. Epub 2012 Apr 25.
4
Emergence of nosocomial New Delhi metallo-β-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait.科威特一家三级护理医院收治的患者中出现产新德里金属β-内酰胺酶1(NDM-1)的医院内肺炎克雷伯菌。
Int J Antimicrob Agents. 2012 Feb;39(2):183-4. doi: 10.1016/j.ijantimicag.2011.10.002. Epub 2011 Nov 22.
5
Characterization of purified New Delhi metallo-β-lactamase-1.新型德里金属β-内酰胺酶-1 的特性分析。
Biochemistry. 2011 Nov 22;50(46):10102-13. doi: 10.1021/bi201449r. Epub 2011 Nov 1.
6
Structure of apo- and monometalated forms of NDM-1--a highly potent carbapenem-hydrolyzing metallo-β-lactamase.NDM-1 无金属和单金属形式的结构——一种高效的碳青霉烯水解金属β-内酰胺酶。
PLoS One. 2011;6(9):e24621. doi: 10.1371/journal.pone.0024621. Epub 2011 Sep 8.
7
SMB-1, a novel subclass B3 metallo-beta-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate.一株耐碳青霉烯类黏质沙雷氏菌临床分离株中,与 ISCR1 和一个 class 1 整合子有关的新型 B3 型金属β-内酰胺酶 SMB-1。
Antimicrob Agents Chemother. 2011 Nov;55(11):5143-9. doi: 10.1128/AAC.05045-11. Epub 2011 Aug 29.
8
A structural view of the antibiotic degradation enzyme NDM-1 from a superbug.超级细菌中抗生素降解酶 NDM-1 的结构视图。
Protein Cell. 2011 May;2(5):384-94. doi: 10.1007/s13238-011-1055-9. Epub 2011 Jun 2.
9
Metallo-β-lactamases: a last frontier for β-lactams?金属β-内酰胺酶:β-内酰胺类药物的最后一道防线?
Lancet Infect Dis. 2011 May;11(5):381-93. doi: 10.1016/S1473-3099(11)70056-1.
10
Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism.NDM-1 的晶体结构揭示了一种常见的β-内酰胺水解机制。
FASEB J. 2011 Aug;25(8):2574-82. doi: 10.1096/fj.11-184036. Epub 2011 Apr 20.